Mesa Laboratories (MLAB) Stock Price, News & Analysis

Company Overview

Mesa Laboratories, Inc. (NASDAQ: MLAB) is a global provider of instrumentation products designed for critical process monitoring, testing and calibration. Headquartered in Lakewood, Colorado, the company serves a diverse set of end markets including healthcare, pharmaceutical, food and beverage, energy and industrial sectors. With a focus on precision measurement and validation, Mesa Laboratories helps customers ensure regulatory compliance, product safety and operational efficiency across complex manufacturing and sterilization processes.

The company’s product portfolio encompasses biological and chemical indicators for sterilization process validation, digital data loggers and sensors for environmental monitoring, and optical gas analyzers with sample-conditioning solutions for oil, gas and petrochemical applications. Mesa Laboratories also offers calibration standards, software platforms and technical support services that enable clients to maintain accurate instrument performance and fulfill industry-specific quality assurance requirements.

Since its founding in 1968, Mesa Laboratories has expanded through a combination of in-house research and development and strategic acquisitions to broaden its instrumentation offerings and geographic reach. The company maintains manufacturing and service facilities across North America, Europe and the Asia-Pacific region, leveraging a global distribution network to deliver products and support to customers in more than 100 countries.

Key Stats

• Today's Range: $98.09 to $105.92
• 50-Day Range: $73.23 to $106.12
• 52-Week Range: $55.45 to $131.20
• Volume: 171,625 shs
• Average Volume: 111,973 shs
• Market Capitalization: $577.67 million
• P/E Ratio: 163.52
• Dividend Yield: 0.61%
• Price Target: $94.00
• Consensus Rating: Reduce

Mesa Laboratories Stock Analysis - MarketRank™

Mesa Laboratories scored higher than 67% of companies evaluated by MarketBeat, and ranked 240th out of 859 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.0 / 5
• Analyst Rating: Reduce

Consensus Rating

Mesa Laboratories has received a consensus rating of Reduce. The company's average rating score is 1.67, and is based on no strong buy ratings, no buy ratings, 2 hold ratings, and 1 sell rating.

Downside Risk

Mesa Laboratories has a consensus price target of $94.00, representing about 10.2% downside from its current price of $104.65.

Amount of Analyst Coverage

Mesa Laboratories has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 20.39%

Earnings Growth

Earnings for Mesa Laboratories are expected to grow by 20.39% in the coming year, from $7.26 to $8.74 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Mesa Laboratories is 163.52, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 38.09.

Price to Earnings Ratio vs. Sector

The P/E ratio of Mesa Laboratories is 163.52, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 20.64.

Price to Book Value per Share Ratio

Mesa Laboratories has a P/B Ratio of 3.56. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

3.78% of the float of Mesa Laboratories has been sold short.

Short Interest Ratio / Days to Cover

Mesa Laboratories has a short interest ratio ("days to cover") of 1.89, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Mesa Laboratories has recently decreased by 10.12%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.8 / 5
• Dividend Strength: Weak

Dividend Yield

Mesa Laboratories has a dividend yield of 0.60%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

Mesa Laboratories does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Mesa Laboratories is 100.00%. Payout ratios above 75% are not desirable because they may not be sustainable.

Dividend Sustainability

Based on earnings estimates, Mesa Laboratories will have a dividend payout ratio of 7.32% next year. This indicates that Mesa Laboratories will be able to sustain or increase its dividend.

News and Social Media

• Score: 3.7 / 5
• News Sentiment: 0.89

News Sentiment

Mesa Laboratories has a news sentiment score of 0.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.44 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for Mesa Laboratories this week, compared to 1 article on an average week.

Search Interest

3 people have searched for MLAB on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days.

Company Ownership

• Score: 4.5 / 5
• Insider Trading: Acquiring Shares

Cluster Insider Buying

3 insiders have purchased shares of Mesa Laboratories in the last three months. Multiple insiders buying is a strong bullish signal.

Net Insider Buying

Over the last three months, insiders have purchased a net $452,076.00 in company stock, which represents 0.0783% of the company's market cap.

Insider Buying vs. Insider Selling

In the past three months, Mesa Laboratories insiders have bought more of their company's stock than they have sold. Specifically, they have bought $452,076.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

4.90% of the stock of Mesa Laboratories is held by insiders.

Percentage Held by Institutions

90.60% of the stock of Mesa Laboratories is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 2/03/2026
• Ex-Dividend for 3/16 Dividend: 2/27/2026
• Record date for 3/16 Dividend: 2/28/2026
• Dividend Payable: 3/16/2026
• Today: 5/08/2026
• Next Earnings (Estimated): 5/27/2026
• Record date for 6/15 Dividend: 5/29/2026
• Ex-Dividend for 6/15 Dividend: 5/29/2026
• Dividend Payable: 6/15/2026
• Fiscal Year End: 3/31/2027

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: Electronic Equipment & Instruments
• Current Symbol: NASDAQ:MLAB
• CIK: 724004
• Web: www.mesalabs.com
• Phone: (303) 987-8000
• Fax: 303-987-8989
• Employees: 680
• Year Founded: 1982

Price Target and Rating

• Average Price Target for Mesa Laboratories: $94.00
• High Price Target: $94.00
• Low Price Target: $94.00
• Potential Upside/Downside: -10.2%
• Consensus Rating: Reduce
• Rating Score (0-4): 1.67
• Research Coverage: 3 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.64
• Trailing P/E Ratio: 163.52
• Forward P/E Ratio: 14.41
• P/E Growth: N/A
• Net Income: -$1.97 million
• Net Margins: 1.51%
• Pretax Margin: 5.68%
• Return on Equity: 22.02%
• Return on Assets: 8.86%

Debt

• Debt-to-Equity Ratio: 0.86
• Current Ratio: 1.94
• Quick Ratio: 1.45

Sales & Book Value

• Annual Sales: $240.98 million
• Price / Sales: 2.40
• Cash Flow: $12.10 per share
• Price / Cash Flow: 8.65
• Book Value: $29.42 per share
• Price / Book: 3.56

Miscellaneous

• Outstanding Shares: 5,520,000
• Free Float: 5,254,000
• Market Cap: $577.67 million
• Optionable: Not Optionable
• Beta: 0.94